Pyrinas, based in Hong Kong, is the real estate investment and management arm of Aeneas Group and an affiliate of the Nasdaq listed Aptorum Group Limited (Nasdaq : APM). Our real estate team incorporates expertise and market knowledge in major areas including acquisition, underwriting, valuation, asset management, and development which enables us to perform the key investment functions in real estate investment.
Aeneas Group is a multi-disciplinary financial institution with cross border capabilities and technology services. Founded in 2005, Aeneas Capital, a wholly owned subsidiary of the Aeneas Group, is regulated by the Securities & Futures Commission in Hong Kong with respect to the regulated activities of asset management, dealing and advising in securities; servicing multi-family offices and UHNW individuals. Since 2017, the licensed corporation has expanded its businesses across a broad range of investment products and regions, efficiently servicing a vast array of professional investors and corporate clients.
Aptorum Group Limited is a Hong Kong based pharmaceutical company currently developing a portfolio of preclinical therapeutic candidates and medical devices, is dedicated to developing and commercializing its portfolio of therapeutic and medical technologies to tackle unmet medical needs observed globally. The company is listed on the Nasdaq Stock Exchange (APM).
By formulating different real estate funds, our goals are (1) to provide access to investors investing in overseas real estate opportunities with a view to achieve the targeted return without undue risk of loss; and (2) to nurture and cultivate health research and intellectual property linking scientists, researchers, investors, and industry participants around the world while providing real estate solutions.